← FDA Warning Letters

EyePoint Pharmaceuticals, Inc.

FDA Warning Letter · 2024-08-27 · Office of Pharmaceutical Quality Operations Division I

Letter

Company
EyePoint Pharmaceuticals, Inc.
Posted Date
2024-08-27
Letter Issue Date
2024-07-12
Issuing Office
Office of Pharmaceutical Quality Operations Division I

Subject

CGMP/Drugs/Adulterated

Source

Authoritative
FDA Warning Letters
Machine
JSON-LD · Markdown